Objective: To find out the combined efficacy of baclofen and intensive rehabilitation in the treatment of spastic cerebral palsy. 
Introduction
Cerebral Palsy (CP) describes a group of permanent disorders of the development of movement and posture, causing activity limitations that are attributed to nonprogressive disturbances that occurred in the developing fetal or infant brain. The motor disorders of cerebral palsy are often accompanied by disturbances of sensation, perception, cognition, communication, and behavior; by epilepsy, and by secondary musculoskeletal problems 1 . In a majority of cases, the predominant motor abnormality is spasticity 2 . Cerebral palsy is the most common childhood disability with a prevalence of 1.5 to3 per 1000 live births 3, 4 . However, in a study at Physical Medicine & Rehabilitation Department of BSMMU 1.72% patients were . diagnosed as CP 5 . Spastic cerebral palsy is the most common type, accounting for 75% of cases which affects a large proportion of this population 6 . Spasticity is one of the common features of cerebral palsy as it contributes to limitations in body structure and function, leading to deformity 7 . Treating the spasticity component of the movement disorder might enable improvement in the performance, participation, and satisfaction in everyday activities of those children 6 . Treatment of spastic cerebral palsy includes physiotherapy along with antispastic medication. Available drugs that are used to treat spasticity include benzodiazepines, baclofen, alpha-adrenergic agonists (tizanidine, clonidine), dantrolene sodium, and gabapentine 8 . Baclofen is a GABA agonist that is used to reduce muscle tone. Intensive rehabilitation may be defined as 1 hourly intervention, 5 days a week, as opposed to a therapy sessions once a week or once every second week 9 . It consists of neurodevelopmental treatment (NDT), therapeutic exercises (TEs) and activities of daily living (ADL) training 10 . The aim of this study was to find out the efficacy of oral baclofen in combination with intensive rehabilitation in reducing spasticity in cerebral palsy.
Methods
A randomized controlled clinical trial was done in Dhaka Medical College Hospital, Dhaka, between January and December 2011. All the spastic cerebral palsy patients seeking treatment in outpatient department of Physical Medicine & Rehabilitation and Pediatrics were the reference population. From reference population, patients enrolled in the study who met the inclusion and exclusion criteria. Sample size estimates suggested that 30 subjects in each group would be sufficient to detect a 5% level of significance. Patients aged between months to 12 years of both sexes; with disorder in the development of movement and posture presumably of cerebral origin started before 2 years of age, presence of spasticity associated with or characterized by increased tone reflexes, clonus or extensor plantar response, and delayed miles stones of development which is improving over time were included in this study. Those with mixed type of cerebral palsy; receiving systemic antispasticity medications or had received phenol and/or botulinum toxin type A injections; past surgical intervention that might interfere with ankle joint movement; neurodegenerative disorders, chromosomal abnormality such as Down syndrome, inborn errors of metabolism such as galactosemia and presence of comorbidity such as epilepsy were excluded.
Procedure: A total number of 60 patients were primarily selected and were randomized into two groups (Group A and Group B), each of which included 30 patients. Complete history and clinical examination were done for all enrolled patients. After taking written informed consent they were finally selected for the study and randomization was done by lottery. In group A only intensive rehabilitation (1 hour daily for 5 days a week for 24 weeks) was given. In group B intensive rehabilitation (1 hour daily for 5 days a week) and oral baclofen (corresponding to approximately 0.3mg/kg a day) in two divided doses was given for 24 weeks. Patients were first assessed with Modified Asworth Scale (MAS) 39 based on muscle tone to determine the extent of spasticity. Then Physician Rating Scale 40 to measure joint angle (crouch) specially by standard goniometer, 46 knee recurvatum, foot contact and overall functional status by Gross Motor Functional Classification System 11 . Then intervention was done by giving oral baclofen with intensive rehabilitation to reduce spasticity in Group B and uniform intensive rehabilitation protocol was applied. After 4 weeks (1 st follow up) during the continuation of drugs, patients were again assessed by principal investigator using before mentioned 3 scales and adverse effect of oral baclofen was recorded in followup sheet. After 8 weeks (2 nd follow up) were again assessed by principal investigator using before mentioned 3 scales and adverse effect of oral baclofen was recorded in follow up sheet. Then follow up assessment was done every 4 weekly at 12 th week,16 th week, 20 th week and lastly 24 th week for total with continuing the drugs using same scales by principal investigator. Both groups were given intensive rehabilitation by an experienced physiotherapist at the department of Physical Medicine & Rehabilitation, Dhaka Medical College Hospital, Dhaka.
Drug administration and titration:
After group allocation, baclofen was given according to following dose schedule. Oral baclofen was started with a very low dose (corresponding to approximately 0.3mg/kg a day) in two divided doses.
Intensive rehabilitation: One hour intensive physiotherapy was done daily for 5 days a week. Activities included in each session were body alignment weight transfer in various positions, bimanual activities and facilitation sequences of movements.
Ethical clearance: Ethical clearance has been obtained from the concerned authority to conduct the research work of study subjects.
Data analysis: Data were collected through a pretested structured questionnaire. Data were processed and analyzed using SPSS version 11.0. Test statistics used to analysis the data were chi-square test and student's 't' test. The level of significance was set 0.05 and p-value of less than 0.05 was considered significant.
Results
A total of 60 patients were recruited to yield 38 male and 22 female, 56.7% male and 43.3% female in IR group and 70% male and 30% female in baclofen + IR group. Mean age (in months) of group A patients was 25.3±2.8 and group B was 37.4±4.9. In this study, the patients of intensive rehabilitation group were relatively younger compared to Baclofen + IR group (p = 0.040). Though male gender predominant in both groups but sex distribution was not significant (p=0.284). Mean weight was considerably higher in Baclofen + IR group compared to intensive rehabilitation group (p=0.147). Baseline characteristics shows that Modified Ashworth Scale (MAS) grade was almost identical between intensive rehabilitation and Baclofen + IR groups (p=0.249). The physician rating scale in terms of knee recurvatum, angle for crouch gait and foot contact were almost identical between the two groups (p=0.601, p=0.141 and p=0.600). However, the gross motor function was significantly worse in the Baclofen + IR group than that in the intensive rehabilitation group (p=0.036 respectively). .003 respectively). At 6 months, 76.7% of children in the group B showed MAS Grade 0-1 compared to 3.3% in the group A (p<0.001). Most of the children in both groups had no recurvatum of knee (p=0.389). The incidence of mild angle for crouch gait, flat foot and gross motor function were significantly higher in group B than those in the group A (p<0.001, p<0.001 and p=0.001 respectively) ( Table-III) . Figures in the parenthesis denote corresponding %; * 2 Test was employed to analyse the data.
In the intensive rehabilitation group, majority of children changed their Asworth Scale Score from 4 -5 at baseline to 2 -3 at month 6, while in the baclofen + IR group majority changed their score from 4 -5 at baseline to 0 -1 at month 6. Although both group experienced a significant change from their baseline status, the change was more pronounced in the baclofen + IR group (p<0.001) than that in the intensive rehabilitation group (p=0.007).
Most of the children in intensive rehabilitation group with level 5 and 4 gross motor function at baseline changed to level 4 and 3 respectively (p=0.009). Likewise a substantial proportion of children in baclofen + IR group changed from level 5 gross motor function to level 4 and a few to 3 and 2 (p<0.001).
Discussion
In this study, 60 children with cerebral palsy were divided into two groups (30 IR and another 30 baclofen+IR group). At the baseline evaluation baclofen+IR group; 4(13.3%) Although no studies on the use of baclofen to treat children was found, it is still commonly recommended as a treatment option for children with spasticity 15, 16 . Baclofen is stable in liquid form, but can only be given enterally (except if given intrathecally). Baclofen cannot be given intravenously and is not absorbed rectally 17 . Children can have similar withdrawal symptoms as in adults, which includes hallucinations and seizure 18 . The usually starting dose is 2.5mg a day and titrated up every 3-5 days to a maximum of 20-60mg. per day 19 . In a study of infants receiving physical therapy, Scherzer et al noted improvement in broadly defined motor and social skills and in the patient's ability to address the children's daily needs, but could not separate the influences of age, therapy and cognitive level 13 . In the study in Norway to assess the effects of intensive physiotherapy in cerebral palsy. A single-subject design was used. Intervention consisted of two 4-week periods of daily physiotherapy, interrupted by 8 weeks of physiotherapy as usual. The children were assessed every 4th week using the Gross Motor Function Measure. Results were visually analyzed, and statistical significance of Gross Motor Function Measure-66 scores was established with the 2 SD band method. Compliance was high. All infants showed gross motor progress compared with baseline, but separating effect of daily physiotherapy from physiotherapy as usual was inconclusive. Parents preferred the intensive treatment alternative. Blocks of intensive therapy can be an alternative to regular dosage of physiotherapy, however, until further studies are conducted, the physiotherapy intervention, intensity, and frequency should be tailored to meet the needs of each individual infant and family 20 .
Analytical findings of this study showed that combined baclofen and intensive rehabilitation is more beneficial to decrease stiffness and spasm and thereby improving movement in a young child with cerebral palsy.
Conclusion
The study showed that basic motor abilities and self-care improved after intensive physiotherapy with baclofen is effective for reducing generalized spasticity regarding muscle tone and joint angle stiffness and gait improvement in cerebral palsy patients over intensive rehabilitation.
